Capricor’s data clash and a fugitive in the C-suite
Source ↗
👁 1
💬 0
Is the Food and Drug Administration taking inconsistent approaches to Duchenne muscular dystrophy drugs? How will a new batch of drug executives shake up their companies? And why is Adam talking to a recruiter?
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Read the rest…
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Read the rest…
Comments (0)